Hopp til hovedinnhold

Lassafeber

Lassafeber er en såkalt viral hemoragisk feber som er endemisk i Vest-Afrika. Sykdomsforløpet kan i starten være vanskelig å skille fra malaria eller tyfoidfeber.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/livsstil/reise/lassafeber/ 

Hva er lassafeber?

Årsak

Symptomer

Diagnostikk

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Lassafeber. Referanselisten for dette dokumentet vises nedenfor.

  1. Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ 2003; 327: 1271-5. PubMed 
  2. World Health Organization. Lassa fever fact sheet, visited 15.07.2020. www.who.int 
  3. CDC. Lassa fever. Center for Disease Control and Prevention, 2015 .
  4. Healing T, Gopal R. Report on an assessment visit to Sierra Leone, April 12th-30th 2001. London: Merlin, 2001.
  5. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 1987;155: 456-64. PubMed 
  6. Chen JP, Cosgriff TM. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul Fibrinolysis 2000;11: 461-83. PubMed 
  7. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987;155: 437-44. PubMed 
  8. Houlihan C, Behrens R. Lassa fever. BMJ 2017; 358: j2986. doi:10.1136/bmj.j2986 DOI 
  9. Murdoch D. Diseases potentially acquired by travel to sub-Saharan Africa. UpToDate, last updated Nov 5, 2013. UpToDate 
  10. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, et al. Acute sensorineural deafness in Lassa fever. JAMA 1990;264: 2093-6. Journal of the American Medical Association 
  11. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995;311: 857-9. British Medical Journal 
  12. Merlin. `Licking' Lassa fever: a strategic review. London: Merlin, 2002. (www.merlin.org.uk/uploads/files/pr/Lassa%20Fever%20Strategy%202.pdf)
  13. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314: 20-6. New England Journal of Medicine